Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kara A. Hutka, PharmD

Articles by Kara A. Hutka, PharmD

Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus

ByKaren J. McConnell, PharmD,Emily B. Zadvorny, PharmD,Anne M. Denham, PharmD,Sheila L. Kasten, PharmD,Kara A. Hutka, PharmD,Cedar R. Koetting, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group

October 1st 2007

Latest Updated Articles

Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
October 1st 2007

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered